Caroline Augusto Barros

Dr. Caroline Augusto Barros


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2021 in Viruses
Verified
Journal Article
Open access
PDF file
ISIvanildo Sousa
Ivanildo Sousa
Flavia Barreto Dos SantosFlavia Barreto Dos Santos
Flavia Barreto Dos Santos
VPVanessa de Paula
Vanessa de Paula
Tuane C. R. G. VieiraTuane C. R. G. Vieira
Tuane C. R. G. Vieira
HDHelver Dias
Helver Dias
ESEdson Silva
Edson Silva
Virus-induced infections of the central nervous system (CNS) are among the most serious problems in public health and can be associated with high rates of morbidity and mortality, mainly in low- and middle-income countries, where these manifestations have been neglected. Typically, herpes simplex virus 1 and 2, varicella-zoster, and enterovirus are responsible for a high number of cases in immunocompetent hosts, whereas other herpesviruses (for example, cytomegalovirus) are the most common in immunocompromised individuals. Arboviruses have also been associated with outbreaks with a high burden of neurological disorders, such as the Zika virus epidemic in Brazil. There is a current lack of understanding in Brazil about the most common viruses involved in CNS infections. In this review, we briefly summarize the most recent studies and findings associated with the CNS, in addition to epidemiological data that provide extensive information on the circulation and diversity of the most common neuro-invasive viruses in Brazil. We also highlight important aspects of the prion-associated diseases. This review provides readers with better knowledge of virus-associated CNS infections. A deeper understanding of these infections will support the improvement of the current surveillance strategies to allow the timely monitoring of the emergence/re-emergence of neurotropic viruses.

2 September 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
VRVanessa P. Rocha
Vanessa P. Rocha
SCSamir P. C. Campos
Samir P. C. Campos
CBCaroline Augusto Barros
Caroline Augusto Barros
PTPablo Trindade
Pablo Trindade
LSLeticia R. Q. Souza
Leticia R. Q. Souza
RGRafael Braga Gonçalves
Rafael Braga Gonçalves
Bovine lactoferrin (bLf) is a multifunctional protein widely associated with anticancer activity. Prostate cancer is the second most frequent type of cancer worldwide. This study was aimed at evaluating the influence of bLf on cell viability, cell cycle progression, reactive oxygen species (ROS) production, and rate of apoptosis in the human prostate cancer cell line (DU‐145). MTT assay and trypan blue exclusion were used to analyze cell viability. Morphological changes were analyzed through optical microscopy after 24 h and 48 h of bLf treatment. FITC‐bLf internalization and cellular damage were observed within 24 h by confocal fluorescence microscopy. Cell cycle analyses were performed by flow cytometry and propidium iodide. For caspases 3/7 activation and reactive oxygen species production evaluation, cells were live‐imaged using the high‐throughput system Operetta. The cell viability assays demonstrated that bLf induces cell death and morphological changes after 24 h and 48 h of treatment compared to control on DU‐145 cells. The bLf internalization was detected in DU‐145 cells, G1‐phase arrest of the cell cycle, caspase 3/7 activation, and increased oxidative stress on bLf‐treated cells. Our data support that bLf has an important anticancer activity, thus offering new perspectives in preventing and treating prostate cancer.

28 September 2021 in Heliyon
Verified
Journal Article
Open access
CBCaroline Augusto Barros
Caroline Augusto Barros
DSDaniel Sanches
Daniel Sanches
Carlos A. M. CarvalhoCarlos A. M. Carvalho
Carlos A. M. Carvalho
RSRonimara Aparecida Santos
Ronimara Aparecida Santos
TSTheo Luiz Ferraz de Souza
Theo Luiz Ferraz de Souza
RGRafael Braga Gonçalves
Rafael Braga Gonçalves
Lactoferrin (Lf) is an iron-binding glycoprotein and a component of many external secretions with a wide diversity of functions. Structural studies are important to understand the mechanisms employed by Lf to exert so varied functions. Here, we used guanidine hydrochloride and high hydrostatic pressure to cause perturbations in the structure of bovine Lf (bLf) in apo and holo (unsaturated and iron-saturated, respectively) forms, and analyzed conformational changes by intrinsic and extrinsic fluorescence spectroscopy. Our results showed that the iron binding promotes changes on tertiary structure of bLf and increases its structural stability. In addition, we evaluated the effects of bLf structural change on the kinetics of bLf internalization in Vero cells by confocal fluorescence microscopy, and observed that the holo form was faster than the apo form. This finding may indicate that structural changes promoted by iron binding may play a key role in the intracellular traffic of bLf. Altogether, our data improve the comprehension of bLf stability and uptake, adding knowledge to its potential use as a biopharmaceutical.

13 May 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
Carlos A. M. CarvalhoCarlos A. M. Carvalho
Carlos A. M. Carvalho
AMAline da Rocha Matos
Aline da Rocha Matos
BCBraulia Costa Caetano
Braulia Costa Caetano
ISIvanildo Sousa
Ivanildo Sousa
SCSamir Pereira da Costa Campos
Samir Pereira da Costa Campos
RGRafael Braga Gonçalves
Rafael Braga Gonçalves
Since its emergence in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been posing a serious threat to public health worldwide as the causative agent of coronavirus disease 2019 (COVID-19). Now distributed in a pandemic pattern, this disease still lacks an effective drug treatment with low toxicity, leading pharmaceutical companies and research labs to work against time to find a candidate molecule to efficiently treat the affected patients. Due to the well-known broad-spectrum antimicrobial activity of the lactoferrin protein, we sought to verify whether its bovine form (bLf) would also be effective in vitro against SARS-CoV-2. Using an antiviral assay based on quantitative reverse transcription-polymerase chain reaction (qRT-PCR), we found that bLf reduced progeny virus yield by up to ∼84,6% in African green monkey kidney epithelial cells (Vero E6) and ∼68,6% in adenocarcinomic human alveolar basal epithelial cells (A549) at 1 mg/mL, a concentration previously shown to have low cytotoxicity. Therefore, our preliminary data suggest that bLf has the potential to constitute a biochemical approach to fight the new coronavirus pandemic.

25 September 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
NANathalia dos Santos Alves
Nathalia dos Santos Alves
AAADRIANA DE SOUZA Azevedo
ADRIANA DE SOUZA Azevedo
BDBrenda de Moura Dias
Brenda de Moura Dias
IHIngrid Siciliano Horbach
Ingrid Siciliano Horbach
BSBruno P. Setatino
Bruno P. Setatino
RGRafael Braga Gonçalves
Rafael Braga Gonçalves
Despite the rapid mass vaccination against COVID-19, the emergence of new SARS-CoV-2 variants of concern, such as omicron, is still a great distress, and new therapeutic options are needed. Bovine lactoferrin (bLf), a multifunctional iron-binding glycoprotein available in unsaturated (apo-bLf) and saturated (holo-bLf) forms, has been shown to exert broad-spectrum antiviral activity against many viruses. In this study, we evaluated the efficacy of both forms of bLf at 1 mg/mL against infection of Vero cells by SARS-CoV-2. As assessed with antiviral assays, an equivalent significant reduction in virus infection by about 70% was observed when either form of bLf was present throughout the infection procedure with the SARS-CoV-2 ancestral or omicron strain. This inhibitory effect seemed to be concentrated during the early steps of virus infection, since a significant reduction in its efficiency by about 60% was observed when apo- or holo-bLf were incubated with the cells before or during virus addition, with no significant difference between the antiviral effects of the distinct iron-saturation states of the protein. However, an ultrastructural analysis of bLf treatment during the early steps of virus infection revealed that holo-bLf was somewhat more effective than apo-bLf in inhibiting virus entry. Together, these data suggest that bLf mainly acts in the early events of SARS-CoV-2 infection and is effective against the ancestral virus as well as its omicron variant. Considering that there are no effective treatments to COVID-19 with tolerable toxicity yet, bLf shows up as a promising candidate.

6 April 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
CBCaroline Augusto Barros
Caroline Augusto Barros
Tuane C. R. G. VieiraTuane C. R. G. Vieira
Tuane C. R. G. Vieira
Lactoferrin (Lf) is a multifunctional glycoprotein with well-established antimicrobial, anti-inflammatory, and iron-binding properties. Emerging evidence suggests that Lf also plays a neuroprotective role, particularly in neurodegenerative disorders characterized by protein aggregation, such as Parkinson’s disease (PD). Alpha-synuclein (aSyn) aggregation is a pathological hallmark of PD and other synucleinopathies, contributing to neuronal dysfunction and disease progression. Recent studies indicate that Lf may interfere with aSyn aggregation, iron chelation, and modulation of oxidative stress and neuroinflammation. Additionally, Lf’s ability to cross the blood-brain barrier and its potential impact on the gut-brain axis highlight its promise as a therapeutic agent. This review explores Lf’s mechanisms of action in synucleinopathies, its potential as a disease-modifying therapy, and innovative delivery strategies that could enhance its clinical applicability. By addressing the pathological and therapeutic dimensions of aSyn aggregation, we propose Lf as a compelling candidate for future research and clinical development in neurodegenerative diseases.